| Kiefe, Catarina I |
| Completed | N/A | 493756 | US | Suicide Risk Screening, Safety Planning, Care transition facilitation, A Lean Implementation Strategy | University of Massachusetts, Worcester, National Institute of Mental Health (NIMH) | Suicide | 12/23 | 12/23 | | |
| Boudreaux, Edwin D |
| Recruiting | N/A | 670 | US | Jaspr App + JAH, ETAU, Enhanced Treatment As Usual | University of Massachusetts, Worcester, Ohio State University, Evidence-Based Practice Institute, Seattle, WA, Worcester Polytechnic Institute, National Institute of Mental Health (NIMH), University of Colorado, Denver | Suicidal Ideation, Suicide Attempt, Self Harm | 04/27 | 04/27 | | |
| Recruiting | N/A | 44000 | US | Telehealth in preventing suicide (TIPS), Modified ED-SAFE, Treatment as Usual (TAU) | University of Massachusetts, Worcester, Community HealthLink, Collective Medical, National Institute of Mental Health (NIMH) | Suicide Risk | 09/25 | 09/25 | | |
| Recruiting | N/A | 102 | US | OARSCM Software Application, Opioid Addiction Recovery Support - Contingency Management (OARSCM), MyMAT Software Application, MyMAT | Q2i, LLC, University of Massachusetts, Worcester, National Institute on Drug Abuse (NIDA) | Opioid Use Disorder | 05/25 | 05/25 | | |
| Completed | N/A | 493756 | US | Suicide Risk Screening, Safety Planning, Care transition facilitation, A Lean Implementation Strategy | University of Massachusetts, Worcester, National Institute of Mental Health (NIMH) | Suicide | 12/23 | 12/23 | | |
| Enrolling by invitation | N/A | 27908 | US | Jaspr App | University of Massachusetts, Worcester, Ohio State University, Evidence-Based Practice Institute, Seattle, WA, National Institute of Mental Health (NIMH), Worcester Polytechnic Institute, University of Colorado, Denver | Suicidal Ideation, Suicide Attempt, Self Harm | 06/27 | 06/27 | | |
| Messina, Louis |
ATLAS, NCT04800692: The Effects of Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication |
|
|
| Recruiting | 1 | 10 | US | Tetrahydrobiopterin 10 mg/kg, sapropterin, kuvan, Tetrahydrobiopterin 20 mg/kg, L-Ascorbate, L-Arginine | Louis Messina, BioMarin Pharmaceutical | Claudication, Intermittent, Peripheral Artery Disease, Peripheral Vascular Diseases | 07/25 | 12/25 | | |
| Cave, David |
NCT04605302: Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms |
|
|
| Completed | N/A | 27 | US | MCC/MCC-T, Magnetic controlled capsule endoscopy with/without tether, Standard gastroscopy, EGD | AnX Robotica Corp. | Upper Gastrointestinal Symptoms | 06/21 | 03/23 | | |
NCT04724291: MAGNET (Magnetically Controlled Capsule for Assessment of Gastric Mucosa in Symptomatic Patients) |
|
|
| Completed | N/A | 43 | US | MAGNET | George Washington University | Abdominal Pain, Gastritis, Gastric Ulcer, Gastric Cancer | 06/22 | 06/23 | | |
SODA, NCT03771508: Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments |
|
|
| Recruiting | N/A | 8000 | US | | Medtronic - MITG | Small Intestine Disease, Small Intestine Cancer, Small Intestinal Ulcer Bleeding, Small Intestine Obstruction, Small Intestine Adenocarcinoma, Small Intestine Polyp | 12/25 | 12/25 | | |
| Foley, Anne |
NCT04247542: ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection |
|
|
| Completed | 2 | 53 | US | Ibezapolstat, ACX-362E, Vancomycin, Vancomycin oral | Acurx Pharmaceuticals Inc. | Clostridium Difficile Infection | 10/23 | 11/23 | | |
| Recruiting | 2 | 50 | Europe, US | INT-787, Placebo | Intercept Pharmaceuticals, Intercept Pharmaceuticals, Inc. | Alcohol Associated Hepatitis | 12/24 | 03/25 | | |
NCT04605302: Comparative Study of MCCE With/Without Tether vs Conventional Upper Endoscopy in Patients With Upper Abdominal Symptoms |
|
|
| Completed | N/A | 27 | US | MCC/MCC-T, Magnetic controlled capsule endoscopy with/without tether, Standard gastroscopy, EGD | AnX Robotica Corp. | Upper Gastrointestinal Symptoms | 06/21 | 03/23 | | |
NCT03562741: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile |
|
|
| Recruiting | N/A | 500 | US | Fecal Microbiota Transplantation | Krunal Patel | Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection | 01/26 | 01/27 | | |
SODA, NCT03771508: Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments |
|
|
| Recruiting | N/A | 8000 | US | | Medtronic - MITG | Small Intestine Disease, Small Intestine Cancer, Small Intestinal Ulcer Bleeding, Small Intestine Obstruction, Small Intestine Adenocarcinoma, Small Intestine Polyp | 12/25 | 12/25 | | |
| Connelly, Patrick |
BONE, NCT04615260: Rate of Bony Fusion Using NanoBone® Synthetic Bone Graft Versus Local Autologous Bone Graft. |
|
|
| Recruiting | N/A | 40 | US | NanoBone, NanoHA (SiO2) | Artoss Inc. | Degenerative Disc Disease, Spondylolisthesis | 12/24 | 04/25 | | |
| Mijares, Michael |
NCT06774079: Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients |
|
|
| Not yet recruiting | 4 | 24 | US | Tirzepatide, Mediterranean diet | University of Miami | Crohn Disease | 03/26 | 03/26 | | |
| Recruiting | 3 | 406 | Europe, Canada, Japan, US, RoW | Ianalumab, VAY736, Placebo | Novartis Pharmaceuticals, Novartis Pharma AG | Systemic Lupus Erythematosus | 01/27 | 04/29 | | |
| Recruiting | 3 | 420 | Europe, Canada, US, RoW | ianalumab s.c. q4w, VAY736, ianalumab s.c. q12w, placebo s.c., placebo | Novartis Pharmaceuticals, Novartis Pharma AG | Lupus Nephritis | 03/27 | 07/30 | | |
NCT04781543 / 2020-005764-62: A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis |
|
|
| Active, not recruiting | 2/3 | 301 | Europe, Japan, US, RoW | HZN-825 BID, Placebo, HZN-825 QD | Amgen, Horizon Therapeutics USA, Inc | Diffuse Cutaneous Systemic Sclerosis, Sclerosis, Systemic | 09/25 | 09/25 | | |
|
REVITA-T2Di, NCT04419779: Evaluation of the Efficacy and Safety of DMR Using the Revita® in Subjects With Inadequately Controlled Type 2 Diabetes |
|
|
| Suspended | N/A | 320 | Europe, US | Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing (Sham) | Fractyl Health Inc. | Type 2 Diabetes | 06/25 | 01/26 | | |
SODA, NCT03771508: Prospective Collection of PillCam SB3 Videos and Raw Data Files for Future Developments |
|
|
| Recruiting | N/A | 8000 | US | | Medtronic - MITG | Small Intestine Disease, Small Intestine Cancer, Small Intestinal Ulcer Bleeding, Small Intestine Obstruction, Small Intestine Adenocarcinoma, Small Intestine Polyp | 12/25 | 12/25 | | |
